Press release
North America precision medicine Market Analysis by Market Segment, Demand, Trend, Forecast| Abbott, GE Healthcare, Johnson & Johnson, etc.
Precision medicine is a highly effective, modern process of medical diagnosis and treatment of diseases using relevant data around a patients genetic make-up, supported by environmental and behavioral data. North America is the pioneer in adopting technological innovations and advancements in the healthcare sector, which will aid the growth of the market in this region. North America is the highest revenue generating region for the precision medicine market. The increasing adoption of Internet of Medical Things (IoMT) and the use of technologies like gene sequencing, diagnostics, etc., have fueled the growth of precision medicine in this region and the market is at a mature stage in countries like the U.S. and Canada. According to Netscribes, the North American market is projected to expand at a compound annual growth rate (CAGR) of 11.04%, leading to a revenue of USD 36.25 Bn by 2023.
Download Free Report Sample (PDF) Here: https://www.researchreporthub.com/report/north-america-precision-medicine-market/11413/#requestforsample
The North America precision medicine market is classified into three primary segments: based on ecosystem players: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on technology: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.
The diagnostic tools companies are expected to grow at the highest CAGR during the forecasted period of 2018-2023, owing to a rise in the demand for precision medicine. Diagnostic tools and treatments play an important role in the development of precision solutions to determine whether a drug is appropriate for a patient or not.
In the therapeutics segments, cancer therapeutics is expected to show a high growth rate through the forecast period 2018-2023.
Key growth factors
Due to technological advancements in the healthcare sector in North America, the precision medicine market is going to emerge in the coming years. In 2015, the then-President of the United States, Barrack Obama, announced the launch of the Precision Medicine Initiative for a bold new research effort to revolutionize methods to improve health and treat diseases. Therefore, the precision medicine market is going to grow during the forecast period due government initiatives and policies that encourage such technologies.
Threats and key players
Threat to personal information like genetic data, DNA and RNA data, etc., is considered to be a barrier to the growth of the precision medicine market. Thus, the adoption of precision medicine can hit roadblocks due to concerns regarding consumer privacy and data protection. Moreover, the approvals required by pharmaceutical companies from the U.S. Food & Drug Administration (FDA) for a particular drug or treatment is a time-consuming factor, which might be challenging and hinder the growth of the market.
The major players operating in the North America precision medicine market are Abbott, GE Healthcare, Johnson & Johnson, etc.
Get Discount & Customization of this Report Here: https://www.researchreporthub.com/report/north-america-precision-medicine-market/11413/
Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary
Chapter 2: North America precision medicine market - overview
2.1. North America market overview - market trends, drivers and challenges
2.2. Value chain analysis
2.3. Porters Five Forces analysis
2.4. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
2.4. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.4. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. Market size - by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)
2.5. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Revenue from cardiovascular- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Revenue from central nervous system - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. e. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market size - by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
2.6. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
Chapter 3: North America precision medicine market - by countries
3.1. The U.S.
3.1.1. Market overview - market trends, drivers and challenges
3.1.2. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
3.1.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. Market size - by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)
3.1.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. Market size - by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
3.1.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.1.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. Canada
3.2.1. Market overview- market trends, drivers and challenges
3.2.2. Market size - by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
3.2.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. Market size - By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)
3.2.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. Market size - By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
3.2.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. d Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2.4. e Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
………
Get Complete TOC with Figures and Tables Here: https://www.researchreporthub.com/report/north-america-precision-medicine-market/11413/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
Research Report Hub
20 Hanover Square
Mayfair, London W1S 1JY, UK
sales@researchreporthub.com
Web:www.researchreporthub.com
Find us on:
https://www.facebook.com/reasearchreporthub/
https://twitter.com/hub_report
https://www.linkedin.com/company/research-report-hub/
sales@researchreporthub.com
UK: +44 7441 906751
(US/CAN TOLL FREE):1 888-247-2308
Asia: +91 84484 44687
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America precision medicine Market Analysis by Market Segment, Demand, Trend, Forecast| Abbott, GE Healthcare, Johnson & Johnson, etc. here
News-ID: 1528961 • Views: …
More Releases from Research report hub
Global Wine Market is Booming with Market Strategies Adopted By Key Players like …
Wine is an alcoholic drink produced by the fermentation of grapes or other fruits.
Scope of the Report:
The Wine industry concentration is very low; there are about many manufacturers or wineries in the world, and the products mainly from Italy, France, Spain, Australia and USA.
Global manufactures mainly distributed in Europe, Australia and USA. The wineries in Europe have a long history and unshakable status in this field. Wineries in France relative…
Global Microfiber Leather Market Emerging Trends and Prospects by leading Player …
Microfiber leather is a cross-industry product, its development of technology and application related to textiles, plastics, chemicals and other field. The main raw materials of microfiber leather are polyurethane pulp, low density polyethylene, nylon chips, etc.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-microfiber-leather-market-2/47195/#requestforsample
Scope of the Report:
Microfiber Leather production are mainly concentrated in China and Japan at present, the output of this two regions occupy global production more than 80%. Microfiber leather production…
Global Data Monetization Market 2018-2025 Growth Analysis by Key Players, Accent …
Data monetization, a form of monetization, is the act of generating measurable economic benefits from available data sources. Typically these benefits accrue as revenue or expense savings, but may also include market share or corporate market value gains. Data monetization leverages data generated through business operations, available exogenous data or content, as well as data associated with individual actors such as that collected via electronic devices and sensors participating in…
Global Wireline Services Market Emerging Trends and Prospects by leading Players …
Wireline Service is the routine maintenance of a wellbore with wireline tools or any other devices so that well completion operations can be further worked upon. The service uses a cabling technology that a wireline service provider in oil and gas exploration and production business provides. This cabling technology together with the tools perform functions like intervening, pipe recovery and reservoir evaluation, etc.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/global-wireline-services-market/47193/#requestforsample
Scope of the…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
